Christopher Steer

Christopher Steer is Professor of Medicine specializing in Diabetology, practicing medical oncology at Border Medical Oncology and serving as Adjunct Professor at John Richards Centre. His research targets cardiovascular risk reduction in diabetic patients through clinical trials and real-world evidence studies. Current investigations examine GLP-1 receptor agonists, SGLT2 inhibitors, and continuous glucose monitoring systems.

Research spans diabetes technology assessment, cardio-renal protection therapies, and glycemic control metrics. Leadership includes Director of Studies for medical education programs and principal investigator for multinational diabetes trials.